NO2019032I1 - Treosulfan - Google Patents

Treosulfan

Info

Publication number
NO2019032I1
NO2019032I1 NO2019032C NO2019032C NO2019032I1 NO 2019032 I1 NO2019032 I1 NO 2019032I1 NO 2019032 C NO2019032 C NO 2019032C NO 2019032 C NO2019032 C NO 2019032C NO 2019032 I1 NO2019032 I1 NO 2019032I1
Authority
NO
Norway
Prior art keywords
treosulfan
agents
administered
stem cells
combination
Prior art date
Application number
NO2019032C
Other languages
English (en)
Original Assignee
Medac Ges Fuer Klinische Spezialpraeparate Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medac Ges Fuer Klinische Spezialpraeparate Mbh filed Critical Medac Ges Fuer Klinische Spezialpraeparate Mbh
Publication of NO2019032I1 publication Critical patent/NO2019032I1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
NO2019032C 1999-11-05 2019-07-23 Treosulfan NO2019032I1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19953517A DE19953517C1 (de) 1999-11-05 1999-11-05 Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation
PCT/EP2000/010871 WO2001032154A2 (de) 1999-11-05 2000-11-03 Verwendung von treosulfan zur konditionierung von patienten vor knochenmarktransplantation oder blutstammzelltransplantation

Publications (1)

Publication Number Publication Date
NO2019032I1 true NO2019032I1 (no) 2019-07-23

Family

ID=7928187

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20022109A NO329616B1 (no) 1999-11-05 2002-05-02 Anvendelse av treosulfan for fremstilling av et farmasøytisk preparat til bruk i forbindelse med allogen transplantasjon av benmarg eller hematopoetiske stamceller
NO2019032C NO2019032I1 (no) 1999-11-05 2019-07-23 Treosulfan

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20022109A NO329616B1 (no) 1999-11-05 2002-05-02 Anvendelse av treosulfan for fremstilling av et farmasøytisk preparat til bruk i forbindelse med allogen transplantasjon av benmarg eller hematopoetiske stamceller

Country Status (16)

Country Link
US (1) US7199162B1 (no)
EP (1) EP1227808B1 (no)
JP (1) JP4846151B2 (no)
AT (1) ATE251455T1 (no)
AU (1) AU777527B2 (no)
BG (1) BG65845B1 (no)
CA (1) CA2389896C (no)
CZ (1) CZ299701B6 (no)
DE (2) DE19953517C1 (no)
EA (1) EA004543B1 (no)
ES (1) ES2208435T3 (no)
HU (2) HU227332B1 (no)
NO (2) NO329616B1 (no)
PL (1) PL212132B1 (no)
UA (1) UA73961C2 (no)
WO (1) WO2001032154A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237146A1 (de) 2002-08-13 2004-03-04 Medac Gesellschaft für klinische Spezialpräparate mbH Verwendung von Treosulfan und Derivaten davon zur Behandlung der Multiplen Sklerose
EP3856252A1 (en) 2018-09-26 2021-08-04 medac Gesellschaft für klinische Spezialpräparate mbH Solution comprising treosulfan
PL3856151T3 (pl) 2018-09-26 2024-02-19 Medac Gesellschaft für klinische Spezialpräparate mbH Liofilizat treosulfanu
CN112739421A (zh) 2018-09-26 2021-04-30 默德克学会特殊临床公司 曲奥舒凡的晶型

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
DE4421391C1 (de) * 1994-06-18 1995-11-30 Gsf Forschungszentrum Umwelt Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression
WO2000045842A2 (en) * 1999-02-04 2000-08-10 The General Hospital Corporation Methods for human allografting

Also Published As

Publication number Publication date
DE19953517C1 (de) 2001-08-09
UA73961C2 (uk) 2005-10-17
EP1227808B1 (de) 2003-10-08
CA2389896C (en) 2007-04-10
HU227332B1 (en) 2011-03-28
AU1391801A (en) 2001-05-14
US7199162B1 (en) 2007-04-03
PL212132B1 (pl) 2012-08-31
AU777527B2 (en) 2004-10-21
WO2001032154A2 (de) 2001-05-10
NO329616B1 (no) 2010-11-22
NO20022109L (no) 2002-07-01
JP4846151B2 (ja) 2011-12-28
EA200200535A1 (ru) 2002-10-31
HUP0203277A2 (en) 2003-01-28
ATE251455T1 (de) 2003-10-15
CA2389896A1 (en) 2001-05-10
DE50004024D1 (de) 2003-11-13
HUS1900041I1 (hu) 2019-10-28
BG106772A (bg) 2003-02-28
NO20022109D0 (no) 2002-05-02
ES2208435T3 (es) 2004-06-16
EA004543B1 (ru) 2004-06-24
WO2001032154A3 (de) 2002-01-24
BG65845B1 (bg) 2010-03-31
CZ299701B6 (cs) 2008-10-22
CZ20021562A3 (cs) 2002-10-16
EP1227808A2 (de) 2002-08-07
JP2003513034A (ja) 2003-04-08
PL356240A1 (en) 2004-06-28

Similar Documents

Publication Publication Date Title
NO2019032I1 (no) Treosulfan
DE69937888D1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
EP1100522A4 (en) ADMINISTRATION OF ACTIVE SUBSTANCES BY PULMONARY TRACT
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
YU52099A (sh) Fungicidni trifluormetilalkilamino-triazolpirimidini
CY2473B1 (en) New phenanthridines.
HUP9903072A2 (hu) 5,7-Dihidroxi-kromán-4-on-származékok az immunválasz elnyomására
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
DE60143517D1 (de) Wiederherstellung der gelenken mit mesenchymalen stammzellen
ES2175079T3 (es) Derivados de indol utiles como inhibidores de cgmp-pde.
DK0975634T3 (da) Fungicide trifluorphenyl-triazolpyrimidiner
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
ATE514771T1 (de) Haartransplantation
DK1147088T3 (da) 6-arylphenanthridiner med PDE-IV-inhiberende aktivitet
BR0107544A (pt) Composição de promoção de secreção de bile
DK0793503T3 (da) Anvendelse af hepatocyt-vækstfaktor til inducering af profilerering og differentiering af hemotopoietiske celler
PT1244614E (pt) Inibidores de triptase
ATE311104T1 (de) Trägerlösung für verglasbare konzentrationen von gefrierschutzmitteln und gefrierschutzmittel- mischungen
TR200100159T2 (tr) Antitrombotik maddeler olarak bispiperidinler
DK1194158T3 (da) Anvendelse af UK 114-proteiner til hæmning af organtransplantatafstödning
PL343848A1 (en) Novel benzimidazoles and benzoxazoles
ES2186782T3 (es) Uso de derivados de tropolona como inhibidores de la enzima inositol-monofosfatasa.